Fibroblast Growth Factor Receptor ( FGFR ) Inhibitors in Urothelial Cancer
نویسندگان
چکیده
منابع مشابه
the relationship between polymorphic fibroblast growth factor receptor (fgfr) gene and breast cancer risk
background: genetic factors associated with cancer have been widely investigated and several polymorphisms have been connected with breast cancer. breast cancer (bc) can be considered one of the most popular reasons of death among women. bc, likewise, is the second cause of death in iran. the present research aims at determining the frequency of the fibroblast growth factor receptor (fgfr) gene ...
متن کاملPotent, selective inhibitors of fibroblast growth factor receptor define fibroblast growth factor dependence in preclinical cancer models.
We describe here the identification and characterization of 2 novel inhibitors of the fibroblast growth factor receptor (FGFR) family of receptor tyrosine kinases. The compounds exhibit selective inhibition of FGFR over the closely related VEGFR2 receptor in cell lines and in vivo. The pharmacologic profile of these inhibitors was defined using a panel of human tumor cell lines characterized fo...
متن کاملTherapeutic Discovery Potent, Selective Inhibitors of Fibroblast Growth Factor Receptor Define Fibroblast Growth Factor Dependence in Preclinical Cancer Models
We describe here the identification and characterization of 2 novel inhibitors of the fibroblast growth factor receptor (FGFR) family of receptor tyrosine kinases. The compounds exhibit selective inhibition of FGFR over the closely related VEGFR2 receptor in cell lines and in vivo. The pharmacologic profile of these inhibitors was defined using a panel of human tumor cell lines characterized fo...
متن کاملCharacterisation of small molecule inhibitors of FGFR Key words: Fibroblast Growth Factor Receptor, Vascular Endothelial Growth Factor Receptor, cell signalling, novel molecular therapeutic, fragment based screening
Title Potent, selective inhibitors of FGFR define FGF dependence in pre-clinical cancer models. Authors and Affiliations M Squires, G Ward, G Saxty, V Berdini, A Cleasby, P King, P Angibaud, T Perera, L Fazal, D Ross, C Griffiths Jones, A Madin, R Benning, E Vickerstaffe, A O Brien, M Frederickson, M Reader, C Hamlett, M Batey, S Rich, M Carr, D Miller, R Feltell, A Thiru, S Bethell, L Devine, ...
متن کاملOncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib.
Fibroblast growth factor receptor (FGFR) genetic alterations are frequently observed in cancer, suggesting that FGFR inhibition may be a promising therapy in patients harboring these lesions. Identification of predictive and pharmacodynamic biomarkers to select and monitor patients most likely to respond to FGFR inhibition will be the key to clinical development of this class of agents. Sensiti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Oncologist
سال: 2020
ISSN: 1083-7159,1549-490X
DOI: 10.1634/theoncologist.2020-0334